Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 15, Issue 9
|
pp. 3598–3620
Comprehensive analyses reveal the prognosis and biological function roles of chromatin regulators in lung adenocarcinoma
Back to article
Figure 8
(8 of 10)
−
100%
+
Figure 8.
Chemotherapy sensitivity and immunotherapy response assessment.
(
A
–
I
) IC50 of nine kinds of chemotherapy drug between high- and low-risk groups. (
J
–
M
) Immunotherapy response prediction based on Tumor Immune Dysfunction and Exclude module.